General Information


DRACP ID  DRACP04164

Peptide Name  

Sequence  GKLRLIKKLWVKKWKKKGWKA

Sequence Length  21

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C129H216N36O22

Absent amino acids  CDEFHMNPQSTY

Common amino acids  K

Mass  298029

Pl  12.21

Basic residues  10

Acidic residues  0

Hydrophobic residues  9

Net charge  10

Boman Index  -3047

Hydrophobicity  -100.95

Aliphatic Index  92.86

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  16500

Absorbance 280nm  825

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33677023

Title  Dual antimicrobial and anticancer activity of a novel Synthetic peptide δΌͺ-helical antimicrobial peptide

Doi Not available

Year  2021

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  17934

DRACP is developed by Dr.Zheng's team.